BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28513222)

  • 1. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
    Polonikov A; Bykanova M; Ponomarenko I; Sirotina S; Bocharova A; Vagaytseva K; Stepanov V; Churnosov M; Bushueva O; Solodilova M; Shvetsov Y; Ivanov V
    Clin Exp Hypertens; 2017; 39(4):306-311. PubMed ID: 28513222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.
    Polonikov A; Kharchenko A; Bykanova M; Sirotina S; Ponomarenko I; Bocharova A; Vagaytseva K; Stepanov V; Bushueva O; Churnosov M; Solodilova M
    Gene; 2017 Sep; 627():451-459. PubMed ID: 28687336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
    Hiratsuka M
    Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the CYP2C monooxygenase enzyme subfamily shows no association with longevity in a German population.
    Flachsbart F; Ufer M; Kleindorp R; Nikolaus S; Schreiber S; Nebel A
    J Gerontol A Biol Sci Med Sci; 2011 Nov; 66(11):1186-91. PubMed ID: 21798861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk.
    Polonikov AV; Ponomarenko IV; Bykanova MA; Sirotina SS; Bocharova AV; Vagaytseva KV; Stepanov VA; Azarova IE; Churnosov MI; Solodilova MA
    Hypertens Res; 2019 Feb; 42(2):257-272. PubMed ID: 30518987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    Datkhile KD; Patil SR; Patil MN; Durgawale PP; Jagdale NJ; Deshmukh VN; More AL; Gudur RA; Gudur AK
    J Cancer Res Ther; 2023 Oct; 19(7):1925-1930. PubMed ID: 38376298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
    Uno Y; Murayama N; Yamazaki H
    Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
    Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
    Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive contribution of genes for aryl hydrocarbon receptor signaling pathway to hypertension susceptibility.
    Polonikov AV; Bushueva OY; Bulgakova IV; Freidin MB; Churnosov MI; Solodilova MA; Shvetsov YD; Ivanov VP
    Pharmacogenet Genomics; 2017 Feb; 27(2):57-69. PubMed ID: 27977510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP.
    Tan ML; Yoshida K; Zhao P; Zhang L; Nolin TD; Piquette-Miller M; Galetin A; Huang SM
    Clin Pharmacol Ther; 2018 May; 103(5):854-867. PubMed ID: 28990182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension.
    Dreisbach AW; Japa S; Sigel A; Parenti MB; Hess AE; Srinouanprachanh SL; Rettie AE; Kim H; Farin FM; Hamm LL; Lertora JJ
    Am J Hypertens; 2005 Oct; 18(10):1276-81. PubMed ID: 16202848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
    Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
    Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and function of CYP2C isoforms in human intestine and liver.
    Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
    Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke.
    Yi X; Zhang B; Wang C; Liao D; Lin J; Chi L
    Gene; 2015 Jul; 565(1):85-9. PubMed ID: 25839935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
    Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T
    Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
    Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
    Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
    Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
    BMC Med Genet; 2019 Sep; 20(1):148. PubMed ID: 31477036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.